World's Best Scientists 2026 revealed!
Tapio Visakorpi

Tapio Visakorpi

D-Index & Metrics

Medicine

D-Index
98
Citations
37942
World Ranking
8884
National Ranking
104

Tapio Visakorpi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tapio Visakorpi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 384 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tapio Visakorpi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tapio Visakorpi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tapio Visakorpi is affiliated with Tampere University in Finland and works primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their research focuses heavily on cancer, particularly prostate cancer, with significant contributions in related molecular mechanisms, cancer genomics, diagnostics, and treatment strategies.

The scientist has published extensively on topics such as prostate cancer treatment and research, prostate cancer diagnosis and treatment, cancer genomics and diagnostics, cancer-related molecular mechanisms research, RNA research and splicing, cancer, lipids, and metabolism, as well as immunotherapy and immune responses.

Frequent publication venues for Visakorpi's work include:

  • The Prostate
  • Cancer Research
  • Nature Communications
  • Oncogene
  • bioRxiv (Cold Spring Harbor Laboratory)

Coauthors frequently collaborating with Visakorpi are:

  • Matti Nykter
  • Teuvo L.J. Tammela
  • Jack A. Schalken
  • Leena Latonen
  • Teemu J. Murtola

Selected recent publications include:

  • "Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse," 2021, Nature Communications
  • "Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy," 2020, Nature Communications
  • "Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells," 2021, Oncogene
  • "Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts," 2020, BMC Research Notes
  • "Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer," 2024, Nature Communications

The main subfields that Visakorpi's work addresses include pulmonary and respiratory medicine, cancer research, molecular biology, immunology, and oncology. Their investigations contribute to understanding cancer progression, molecular pathways, and immune interactions within the tumor microenvironment.

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

    Tapio Visakorpi;Eija Hyytinen;Pasi Koivisto;Minna Tanner

  • The evolutionary history of lethal metastatic prostate cancer.

    Gunes Gundem;Peter Van Loo;Peter Van Loo;Peter Van Loo;Barbara Kremeyer;Ludmil B. Alexandrov

  • MicroRNA Expression Profiling in Prostate Cancer

    Kati P. Porkka;Minja J. Pfeiffer;Kati K. Waltering;Robert L. Vessella

  • Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer

    Marika J. Linja;Kimmo J. Savinainen;Outi R. Saramäki;Teuvo L. J. Tammela

  • Androgen Receptor Gene Amplification: A Possible Molecular Mechanism for Androgen Deprivation Therapy Failure in Prostate Cancer

    Pasi Koivisto;Juha Kononen;Christian Palmberg;Teuvo Tammela

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Changes in circulating microRNA levels associated with prostate cancer

    R J Bryant;T Pawlowski;J W F Catto;G Marsden

  • Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

    Wennuan Liu;Sari Laitinen;Sofia Khan;Mauno Vihinen

  • Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer

    Elena S. Martens-Uzunova;René Böttcher;René Böttcher;Carlo M. Croce;Guido Jenster

  • Evidence for a prostate cancer susceptibility locus on the X chromosome.

    Jianfeng Xu;Deborah Meyers;Diha Freije;Sarah Isaacs

  • Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization

    Tapio Visakorpi;Anne H. Kallioniemi;Ann-Christine Syvänen;Eija R. Hyytinen

  • MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

    James W F Catto;Antonio Alcaraz;Anders S. Bjartell;Ralph W deVere White

  • A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

    Ali Amin Al Olama;Zsofia Kote-Jarai;Sonja I. Berndt;David V. Conti

  • Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

    Olli-P. Kallioniemi;Kaija Holli;Tapio Visakorpi;Timo Koivula

  • Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients

    Jorma Isola;Tapio Visakorpi;Kaija Holli;Olli-P. Kallioniemi

  • Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas

    Nina N. Nupponen;Laura Kakkola;Pasi Koivisto;Tapio Visakorpi

  • Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Jose M. C. Tubio;Yilong Li;Young Seok Ju;Inigo Martincorena

  • The molecular genetics of prostate cancer.

    Tapio Visakorpi

  • The evolutionary history of lethal metastatic prostate cancer

    G Gundem;P Van Loo;B Kremeyer;L B Alexandrov

Frequent Co-Authors

Teuvo L.J. Tammela
Teuvo L.J. Tammela Tampere University
Jorma Isola
Jorma Isola Tampere University
William B. Isaacs
William B. Isaacs Johns Hopkins University
Colin Cooper
Colin Cooper University of East Anglia
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research
Robert L. Vessella
Robert L. Vessella University of Washington
David E. Neal
David E. Neal University of Cambridge
Ultan McDermott
Ultan McDermott AstraZeneca (United Kingdom)
Olli Kallioniemi
Olli Kallioniemi Karolinska Institute
David C. Wedge
David C. Wedge University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a range of related healthcare careers that can often be pursued through flexible online programs. For those interested in pharmacy, the 3-year online pharmd pathway offers a practical solution for working professionals who want to advance in the pharmaceutical field.

Health information is another fast-growing area. Earning a him associate degree online prepares students for roles in managing medical records, data integrity, and compliance in healthcare settings.

For those seeking a shorter-term option, the cheapest medical coding certification online can provide a quick entry point into the healthcare industry with skills that are in high demand.

Nursing continues to be a cornerstone of healthcare, and the cheapest online nurse practitioner programs enable registered nurses to advance into higher clinical roles through affordable online study.

These online degree and certification pathways offer accessible routes to rewarding healthcare careers, whether you’re just starting out or looking to specialize further.

Best Scientists Citing Tapio Visakorpi

Trending Scientists

Recently Published Articles